BSE · 544687
Hannah Joseph Hospital Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹93 Cr with net profit ₹11 Cr — a 12.08% net margin, versus 9.26% the period before.
Shareholding
As of 2026-03-31
- Promoter71.28%
- Public19.11%
- FII0.56%
- DII9.05%
376 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.3× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #1 of 85 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,27,048 Cr | 60.38 | 13.42 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,01,000 Cr | 67.47 | 9.4 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹94,359 Cr | 100.61 | 5.73 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹67,025 Cr | 62.83 | 6.77 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,652 Cr | 171.83 | 15.81 | 8.48% | 6.54% |
| Global Health Limited | ₹38,911 Cr | 67.98 | 9.82 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹38,199 Cr | 44.31 | 8.41 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,296 Cr | 154.72 | 8.62 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,042 Cr | 56.97 | 12.78 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,613 Cr | 55.04 | 5.67 | 10.37% | 15.77% |
| Hannah Joseph Hospital Limited(this company) | — | — | — | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashHannah Joseph Hospital Limited is under ESM (Enhanced Supervision Measure) Stage 1 surveillance. In the financial year ending March 2026, the company reported a revenue of Rs 92.5589 Cr and a net profit of Rs 11.1812 Cr. For the same period, its EPS was 6.32.
Positives
- +Revenue increased by 18.82% from Rs 77.9005 Cr in March 2025 to Rs 92.5589 Cr in March 2026.
- +Net profit grew by 55.08% from Rs 7.2099 Cr in March 2025 to Rs 11.1812 Cr in March 2026.
- +Promoter holding of 71.2756% in March 2026 indicates a majority stake.
- +The debt-to-equity ratio is 0.43.
Negatives
- −The company is under ESM Stage 1 surveillance.
- −Promoter holding decreased from 93.5685% in March 2025 to 71.2756% in March 2026.
- −DII holding decreased from 10.1505% in February 2026 to 9.0491% in March 2026.
- −FII holding decreased from 2.3878% in February 2026 to 0.5639% in March 2026.
Financial Performance
Hannah Joseph Hospital Limited's revenue increased by 18.82% from Rs 77.9005 Cr in March 2025 to Rs 92.5589 Cr in March 2026. Net profit grew from Rs 7.2099 Cr in March 2025 to Rs 11.1812 Cr in March 2026, marking a 55.08% increase. EPS also saw a rise from 4.32 in March 2025 to 6.32 in March 2026.
Profitability & Returns
The company's EBITDA increased from Rs 13.818 Cr in March 2025 to Rs 18.9583 Cr in March 2026. The EPS improved from 0.86 in March 2022 to 6.32 in March 2026.
Balance Sheet
Hannah Joseph Hospital Limited has a debt-to-equity ratio of 0.43. The 52-week high for the share price was 128.8, and the 52-week low was 55.99.
Ownership & Pledges
As of March 2026, promoters held 71.2756% of the company's shares. Public shareholding stood at 19.1114%, while DIIs held 9.0491% and FIIs held 0.5639%. There were no promoter pledges reported for March 2026.
Regulatory & Surveillance
Hannah Joseph Hospital Limited is currently under ESM Stage 1 surveillance, specifically for 'ESM' measures. This indicates enhanced supervision by regulatory bodies.
Data as of — price: 2026-09-12 · financials: Mar 26 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Hannah Joseph Hospital Limitedshare price & fundamentals